Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea
Part of paid clinical trials in Sacramento, California.
- Sponsor
- Integrative Skin Science and Research
- Study ID
- NCT06072066
- Status
- Recruiting
Conditions
- Rosacea
- Systemic Inflammation
Eligibility Criteria
- Sex
- ALL
- Age
- 30 Years - 70 Years
- Healthy Volunteers
- Accepted
Interventions
- Skin Barrier Oral Supplement — DIETARY_SUPPLEMENTSupplment powder
Study Details
The purpose of this study is to evaluate how supplementation will alter the skin and the gut barrier and inflammation in those with rosacea.
Key Dates
- Start date
- Nov 22, 2023
- Status verified
- Aug 2024
- Primary completion
- Dec 31, 2024
- Completion
- Dec 31, 2024
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Skin Barrier Oral Supplement
Primary Outcome Measure
Transepidermal water loss (TEWL) [ Time Frame: 8 weeks ]
Central Contacts
- Caitlin Egli916-750-2463
- Milred Min
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Integrative Skin and Research | Sacramento | California | 95815 | Raja Sivamani, MD MS AP (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Sacramento, CA
By research site
Related Studies
- The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic DermatitisRecruiting · Integrative Skin Science and Research · Sacramento, California
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationPHASE3 · Recruiting · Novo Nordisk A/S · Alexander City, Alabama
- Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related ConditionsRecruiting · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Bethesda, Maryland
- Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2PHASE2 · Enrolling By Invitation · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland